Morocco’s medical technology sector is attracting more attention after two major stock market listings in two years. Vicenne listed on the Casablanca Stock Exchange in 2025, followed by T2S in 2026. Both companies raised fresh money to support their growth as Morocco expands healthcare coverage and invests in hospitals.
The listings come as Morocco rolls out compulsory health insurance, upgrades hospitals, creates Regional Health Groups and sees continued growth in private healthcare. These changes are increasing demand for medical equipment, diagnostic tools, maintenance services, software and other hospital technologies.
To support their next stage of growth, both companies turned to the stock market, but through different deals.
Vicenne raised 500 million dirhams through a share issue. The company said all the money will be used to fund its expansion.
T2S raised 1.1 billion dirhams through a deal that combined a 350 million dirham share issue with the sale of 750 million dirhams worth of existing shares.
The share sale allowed Helios Investment Partners to sell part of its stake after several years as an investor. The fund remains T2S’s majority shareholder and the company’s management team has stayed in place. The 350 million dirhams raised for the business will be used to support its growth plans.
Although the two companies have different business models, both are growing.
In 2025, Vicenne reported a net profit margin of 13.3%, compared with 10.1% for T2S. Vicenne’s EBITDA margin reached 24.4%, while T2S reported about 20%.
Vicenne also recorded faster recent growth. Between 2023 and 2025, its revenue increased by 49%, compared with 28% for T2S.
Looking ahead, however, T2S expects to grow faster. Its business plan forecasts annual growth of about 18% over the coming years, compared with around 14% projected by Vicenne when it went public.
The comparison has one important difference. Vicenne’s forecasts were prepared before the acquisitions it plans to make using the money raised from its IPO. The company hopes these acquisitions will help it grow faster and reduce the size gap with T2S.
T2S already has a larger business and aims to almost double its revenue by 2030. It also expects its profit margins to improve as the business grows.
Investors have also valued the companies slightly differently.
T2S was valued at around 18.7 times its expected 2026 net profit. Vicenne was valued at about 16.4 times comparable earnings when it listed.
The gap is relatively small. Investors will now focus on whether both companies deliver on their plans by increasing profits, generating cash, improving margins and managing their finances.
T2S also reported a net debt to equity ratio of about 15%, giving it room to borrow more if needed.
For investors, another key point is where the companies make their money. Sales of medical equipment can vary from year to year, while maintenance, software, consumables and service contracts usually provide more stable income.
Being listed also means both companies must regularly publish financial results, explain their strategy and show how they use the money raised from investors. This could strengthen their reputation with banks, industrial partners and public sector customers.
Rafik Ikram, a specialist in healthcare financing, acquisitions and business valuation, said two IPOs alone are not enough to confirm a lasting trend. However, he said they show that Morocco’s healthcare sector is becoming more structured and that companies are finding new ways to finance their growth.
Jamal Belhabes, managing director of BELC AFRI Consulting and a hospital governance expert, said Vicenne and T2S are the first visible signs of a wider trend. He said private equity has helped prepare companies to bring in new shareholders or join the stock market.
Between 2018 and 2024, stock market listings accounted for nearly 22% of private equity exits in Morocco. More than 160 companies are currently backed by private equity funds, creating a pipeline for future IPOs.
In 2024, companies supported by private equity funds recorded average revenue growth of 20.5%. In healthcare, revenue grew by 59%.
Private equity has also helped companies improve their management. The share of businesses with formal budgeting policies rose from 45% when funds first invested to 99% when they exited.
Together, these developments point to a changing funding model. Venture capital supports young companies, private equity helps businesses grow, and the stock market gives larger companies access to more capital. Bank loans still have an important role, especially for equipment, infrastructure and projects with predictable income, while money raised through IPOs can be used for acquisitions, innovation and international expansion.
